Berthold Henglein
- Molecular Biology top 5%
- Oncology top 1%
- Epidemiology top 5%
- Genetics top 5%
- Cell Biology top 5%
- Co-authors
- Xavier ChenivesseChristian BréchotJian WangPidder Jansen‐DürrAlmut SchulzeDimitry SpitkovskyK. ZerfassJ Wang
- Topics
- Cancer-related Molecular Pathways (14 papers)Virus-based gene therapy research (7 papers)RNA Research and Splicing (4 papers)
- Cited by
- OncologyHepatologyMolecular Biology
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Berthold Henglein
27 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Molecular Biology 2.1k
- Oncology 1.7k
- Epidemiology 571
- Genetics 443
- Cell Biology 415
Countries citing papers authored by Berthold Henglein
This map shows the geographic impact of Berthold Henglein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berthold Henglein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berthold Henglein more than expected).
Fields of papers citing papers by Berthold Henglein
This network shows the impact of papers produced by Berthold Henglein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berthold Henglein. The network helps show where Berthold Henglein may publish in the future.
Co-authorship network of co-authors of Berthold Henglein
This figure shows the co-authorship network connecting the top 25 collaborators of Berthold Henglein. A scholar is included among the top collaborators of Berthold Henglein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berthold Henglein. Berthold Henglein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 160 | |
| 3 | 91 | |
| 4 | 106 | |
| 5 | 89 | |
| 6 | 318 | |
| 7 | 146 | |
| 8 | Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. | 39 |
| 9 | 237 | |
| 10 | Loss of the G1-S control of cyclin A expression during tumoral progression of Chinese hamster lung fibroblasts. | 32 |
| 11 | 80 | |
| 12 | 229 | |
| 13 | Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. | 103 |
| 14 | 194 | |
| 15 | 8 | |
| 16 | Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinomabreakdown → | 552 |
| 17 | 3 | |
| 18 | 80 | |
| 19 | 92 | |
| 20 | 21 |
About Berthold Henglein
Berthold Henglein is a scholar working on Oncology, Genetics and Molecular Biology, having authored 27 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), Virus-based gene therapy research (7 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Oncology (1.7k citations), Hepatology (262 citations) and Molecular Biology (2.1k citations). Berthold Henglein has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Xavier Chenivesse, Christian Bréchot, Jian Wang, Pidder Jansen‐Dürr, Almut Schulze, Dimitry Spitkovsky, K. Zerfass, J Wang, Dirk Eick and J Bergès. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.